Elastin-like recombinamers-based hydrogel modulates post-ischemic remodeling in a non-transmural myocardial infarction in sheep
- 17 February 2021
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 13 (581)
- https://doi.org/10.1126/scitranslmed.aaz5380
Abstract
Ischemic heart disease is a leading cause of mortality due to irreversible damage to cardiac muscle. Inspired by the post-ischemic microenvironment, we devised an extracellular matrix (ECM)–mimicking hydrogel using catalyst-free click chemistry covalent bonding between two elastin-like recombinamers (ELRs). The resulting customized hydrogel included functional domains for cell adhesion and protease cleavage sites, sensitive to cleavage by matrix metalloproteases overexpressed after myocardial infarction (MI). The scaffold permitted stromal cell invasion and endothelial cell sprouting in vitro. The incidence of non-transmural infarcts has increased clinically over the past decade, and there is currently no treatment preventing further functional deterioration in the infarcted areas. Here, we have developed a clinically relevant ovine model of non-transmural infarcts induced by multiple suture ligations. Intramyocardial injections of the degradable ELRs-hydrogel led to complete functional recovery of ejection fraction 21 days after the intervention. We observed less fibrosis and more angiogenesis in the ELRs-hydrogel–treated ischemic core region compared to the untreated animals, as validated by the expression, proteomic, glycomic, and histological analyses. These findings were accompanied by enhanced preservation of GATA4+ cardiomyocytes in the border zone of the infarct. We propose that our customized ECM favors cardiomyocyte preservation in the border zone by modulating the ischemic core and a marked functional recovery. The functional benefits obtained by the timely injection of the ELRs-hydrogel in a clinically relevant MI model support the potential utility of this treatment for further clinical translation.Keywords
Funding Information
- Science Foundation Ireland (13/RC/2073)
- eu (NMP-2014-646075)
- EU FP7 (317304)
- Ministry of Science of the Spanish Government (PCIN-2015-010, MAT2016-78903-R)
This publication has 80 references indexed in Scilit:
- Degradation-mediated cellular traction directs stem cell fate in covalently crosslinked three-dimensional hydrogelsNature Materials, 2013
- PEAKS DB: De Novo Sequencing Assisted Database Search for Sensitive and Accurate Peptide IdentificationMolecular & Cellular Proteomics, 2012
- Age-related Changes in Rat Myocardium Involve Altered Capacities of Glycosaminoglycans to Potentiate Growth Factor Functions and Heparan Sulfate-altered SulfationOnline Journal of Public Health Informatics, 2012
- Temporal and Spatial Expression of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases Following Myocardial InfarctionCardiovascular Therapeutics, 2012
- Recent Trends in the Incidence, Treatment, and Outcomes of Patients with STEMI and NSTEMIThe American Journal of Medicine, 2011
- Controlling the Porosity and Microarchitecture of Hydrogels for Tissue EngineeringTissue Engineering, Part B: Reviews, 2010
- Injectable hydrogel properties influence infarct expansion and extent of postinfarction left ventricular remodeling in an ovine modelProceedings of the National Academy of Sciences of the United States of America, 2010
- Primary contribution to zebrafish heart regeneration by gata4+ cardiomyocytesNature, 2010
- A role for VEGF as a negative regulator of pericyte function and vessel maturationNature, 2008
- Visualizing Metabolically Labeled Glycoconjugates of Living Cells by Copper‐Free and Fast Huisgen CycloadditionsAngewandte Chemie, 2008